Ruba Y. Taha
- Transplantation top 10%
-
- Multiple Myeloma Research and Treatments 6
-
- Chronic Lymphocytic Leukemia Research 8
-
- Lymphoma Diagnosis and Treatment 6
-
- CNS Lymphoma Diagnosis and Treatment 5
-
- Digital Imaging for Blood Diseases 3
-
- PI3K/AKT/mTOR signaling in cancer 2
- Cell death mechanisms and regulation 2
-
- Artificial Intelligence in Healthcare 2
- Co-authors
- Halima El OmriSaba HasanAdel ElomriAbdelfatteh El OmriMatthew S. MetcalfeGavin J. MurphyM L NicholsonRegina Padmanabhan
- Journals
- Frontiers in Oncology (2 papers)International Journal of Environmental Research and Public Health (1 paper)OncoTargets and Therapy (1 paper)
- Partner nations
- QatarEgyptUnited States
In The Last Decade
Ruba Y. Taha
34 papers receiving 328 citations
Peers
Comparison fields: 5 of 78
- Health Informatics 10
- Transplantation 19
- Hematology 42
- Internal Medicine 11
- Cancer Research 44
Countries citing papers authored by Ruba Y. Taha
This map shows the geographic impact of Ruba Y. Taha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruba Y. Taha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruba Y. Taha more than expected).
Fields of papers citing papers by Ruba Y. Taha
This network shows the impact of papers produced by Ruba Y. Taha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruba Y. Taha. The network helps show where Ruba Y. Taha may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ruba Y. Taha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 10 | |
| 9 | 2022 | 16 | |
| 10 | 2021 | 4 | |
| 11 | 2021 | 3 | |
| 12 | 2020 | 5 | |
| 13 | 2020 | 0 | |
| 14 | 2019 | 36 | |
| 15 | 2018 | 49 | |
| 16 | 2010 | 5 | |
| 17 | 2010 | 1 | |
| 18 | 2005 | 6 | |
| 19 | 2004 | 7 | |
| 20 | 2000 | 4 |
About Ruba Y. Taha
Ruba Y. Taha is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 40 papers that have together received 331 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (8 papers), Multiple Myeloma Research and Treatments (6 papers), Lymphoma Diagnosis and Treatment (6 papers), CNS Lymphoma Diagnosis and Treatment (5 papers), Digital Imaging for Blood Diseases (3 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Artificial Intelligence in Healthcare (2 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Health Informatics (10 citations), Transplantation (19 citations) and Hematology (42 citations). Ruba Y. Taha has collaborated with scholars based in Qatar, Egypt and United States. Frequent co-authors include Halima El Omri, Saba Hasan, Adel Elomri, Abdelfatteh El Omri, Matthew S. Metcalfe, Gavin J. Murphy, M L Nicholson, Regina Padmanabhan, Marwa Qaraqe and Said Dermime. Their work appears in journals such as Frontiers in Oncology, International Journal of Environmental Research and Public Health, OncoTargets and Therapy, Biosensors and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.